Ultrathermo Therapeutic Treatment: MiBo ThermoFlo

 MiBo Thermoflo is a FDA class II with exempt therapeutic medical device procedure to treat MGD. It is a Step 2 DED treatment, and it is a non-invasive 20 minute procedure performed. It uses a proprietary thermoelectric heat pump to help maximize liquefaction of meibum, thus improving preservation and function of the evaporative component of the tear film. 

The lids are gently massaged with controlled heat to improve the flow of meibum (oil) through the glands. MiBo Thermoflo procedure improves the function of meibomian glands and protects them long term.

For contact lens wearers, each MiBo Thermoflo procedure often improves wearing time by at least four additional hours. For many of our patients, they report improvement in longer computer work hours and more stable vision. For women patients who wear eye makeup, they report less makeup smearing and watery eyes.

For best results it’s recommended doing 3 treatments 2 weeks apart. Evaluating the patients after the cycle of treatments they might require a 4th treatment. Most patients have been going 12 months before requiring additional treatments but some request frequent treatments for comfort due to daily eyestrain.